Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$8.5 - $12.0 $11,900 - $16,800
-1,400 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$6.26 - $11.03 $10,642 - $18,751
-1,700 Reduced 54.84%
1,400 $9,000
Q4 2020

Jan 21, 2021

BUY
$4.76 - $6.93 $9,520 - $13,860
2,000 Added 181.82%
3,100 $21,000
Q3 2020

Oct 27, 2020

SELL
$4.71 - $7.36 $2,826 - $4,416
-600 Reduced 35.29%
1,100 $6,000
Q2 2020

Jul 22, 2020

BUY
$3.61 - $6.47 $1,805 - $3,235
500 Added 41.67%
1,700 $8,000
Q1 2020

May 07, 2020

SELL
$3.5 - $7.31 $19,250 - $40,205
-5,500 Reduced 82.09%
1,200 $4,000
Q4 2019

Feb 06, 2020

BUY
$4.6 - $7.88 $5,979 - $10,244
1,300 Added 24.07%
6,700 $52,000
Q3 2019

Oct 28, 2019

BUY
$4.89 - $8.0 $23,472 - $38,400
4,800 Added 800.0%
5,400 $30,000
Q2 2019

Aug 09, 2019

BUY
$4.2 - $8.7 $2,520 - $5,220
600 New
600 $5,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $711M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.